Literature DB >> 16210672

Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia.

Sylvia Knapp1, Catharina W Wieland, Sandrine Florquin, Ralph Pantophlet, Lenie Dijkshoorn, Ntambua Tshimbalanga, Shizuo Akira, Tom van der Poll.   

Abstract

RATIONALE: Acinetobacter baumannii is an opportunistic bacterial pathogen that is increasingly associated with gram-negative nosocomial pneumonia, but the molecular mechanisms that play a role in innate defenses during A. baumannii infection have not been elucidated.
OBJECTIVE: To gain first insight into the role of CD14 and Toll-like receptors 4 and 2 in host response to A. baumannii pneumonia.
METHODS: Respective gene-deficient mice were intranasally infected with A. baumannii, and bacterial outgrowth, lung inflammation, and pulmonary cytokine/chemokine responses were determined. To study the importance of LPS in the inflammatory response, mice were also challenged with A. baumannii LPS.
MEASUREMENTS AND MAIN RESULTS: Bacterial counts were increased in CD14 and Toll-like receptor 4 gene-deficient mice, and only these animals developed bacteremia. The pulmonary cytokine/chemokine response was impaired in Toll-like receptor 4 knockout mice and the onset of lung inflammation was delayed. In contrast, Toll-like receptor 2-deficient animals displayed an earlier cell influx into lungs combined with increased macrophage inflammatory protein-2 and monocyte chemoattractant protein-1 concentrations, which was associated with accelerated elimination of bacteria from the pulmonary compartment. Neither CD14 nor Toll-like receptor 4 gene-deficient mice responded to intranasal administration of LPS, whereas Toll-like receptor 2 knockout mice were indistinguishable from wild-type animals.
CONCLUSIONS: Our results suggest that CD14 and Toll-like receptor 4 play a key role in innate sensing of A. baumannii via the LPS moiety, resulting in effective elimination of the bacteria from the lung, whereas Toll-like receptor 2 signaling seems to counteract the robustness of innate responses during acute A. baumannii pneumonia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210672     DOI: 10.1164/rccm.200505-730OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  74 in total

1.  Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection.

Authors:  Brittany L Mortensen; Eric P Skaar
Journal:  Cell Microbiol       Date:  2012-06-14       Impact factor: 3.715

2.  Differential expression of CD14-dependent and independent pathways for chemokine induction regulates neutrophil trafficking in infection.

Authors:  Shalaka Metkar; Kwang Sik Kim; Jack Silver; Sanna M Goyert
Journal:  J Leukoc Biol       Date:  2012-05-16       Impact factor: 4.962

Review 3.  Neutrophil recruitment to the lungs during bacterial pneumonia.

Authors:  Ann Craig; John Mai; Shanshan Cai; Samithamby Jeyaseelan
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

4.  NLRP3 inflammasome pathway has a critical role in the host immunity against clinically relevant Acinetobacter baumannii pulmonary infection.

Authors:  N Dikshit; S D Kale; H J Khameneh; V Balamuralidhar; C Y Tang; P Kumar; T P Lim; T T Tan; A L Kwa; A Mortellaro; B Sukumaran
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

Review 5.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

Review 6.  Why are we afraid of Acinetobacter baumannii?

Authors:  Federico Perez; Andrea Endimiani; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2008-06       Impact factor: 5.091

7.  Lipopolysaccharide-deficient Acinetobacter baumannii shows altered signaling through host Toll-like receptors and increased susceptibility to the host antimicrobial peptide LL-37.

Authors:  Jennifer H Moffatt; Marina Harper; Ashley Mansell; Bethany Crane; Timothy C Fitzsimons; Roger L Nation; Jian Li; Ben Adler; John D Boyce
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

8.  Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii?

Authors:  Anna de Breij; Lenie Dijkshoorn; Ellen Lagendijk; Joke van der Meer; Abraham Koster; Guido Bloemberg; Ron Wolterbeek; Peterhans van den Broek; Peter Nibbering
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

9.  Dissection of host cell signal transduction during Acinetobacter baumannii-triggered inflammatory response.

Authors:  Catalina March; Verónica Regueiro; Enrique Llobet; David Moranta; Pau Morey; Junkal Garmendia; José A Bengoechea
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

10.  Molecular mechanisms of ethanol-induced pathogenesis revealed by RNA-sequencing.

Authors:  Laura Camarena; Vincent Bruno; Ghia Euskirchen; Sebastian Poggio; Michael Snyder
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.